In summary, our data revealed that the downregulation of srGAP1 in CRC tissues is associated with tumor progression and poor prognosis, and srGAP1-Cdc42 regulatory axis is a key downstream target of Slit2-Robo1 pathway in CRC. This evidence concerns the gene SLIT2 and neoplasm.